AGP Executive Report
Last update: 6 hours agoResearch: A Nature Medicine study of 3,328 adults linked AI-detected movement patterns to 1,887 health measures across 18 body systems, suggesting gait analysis could reveal health signals that standard tests miss. Drug Safety: FDA recalled a blood-pressure medicine after pills failed quality checks. Kenyan pharmacists also warned against inserting oral cetirizine vaginally, which can cause discomfort and tissue injury. Rare-Disease Care: South Korea selected vamorolone for a faster reimbursement pathway for Duchenne muscular dystrophy; UK regulators also accepted an application to review an investigational gene therapy for Sanfilippo syndrome. Medicare: CMS finalized a 2.31% physician-fee conversion-factor cut for 2027, alongside changes to 340B and outpatient payments that have drawn concern from care providers. Conflict and Care: An airstrike on a hospital in Myanmar killed a doctor and medical student; in Gaza, a medical student died from wounds sustained in an earlier strike.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
